Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amryt Pharma (DE:3N9A)
STUTTGART:3N9A
Amryt Pharma (3N9A) Financial Statements
0 Followers
Amryt Pharma Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 61.13M | $ 68.54M | $ 59.13M | $ 54.83M | $ 56.52M |
| Gross Profit | $ 27.42M | $ 35.17M | $ 28.35M | $ 25.64M | $ 29.25M |
| EBIT | $ -11.74M | $ -189.00K | $ -13.89M | $ 52.01M | $ -26.31M |
| EBITDA | $ 5.23M | $ 14.68M | $ 935.00K | $ 52.01M | $ -26.31M |
| Net Income Common Stockholders | $ -20.80M | $ -7.05M | $ -14.49M | $ 41.55M | $ -17.21M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 83.25M | $ 90.58M | $ 102.17M | $ 112.77M | $ 123.13M |
| Total Assets | $ 736.88M | $ 764.74M | $ 786.87M | $ 816.06M | $ 855.46M |
| Total Debt | $ 212.79M | $ 217.23M | $ 206.46M | $ 199.18M | $ 202.13M |
| Net Debt | $ 129.54M | $ 126.65M | $ 104.29M | $ 86.41M | $ 79.00M |
| Total Liabilities | $ 412.60M | $ 422.71M | $ 440.88M | $ 459.40M | $ 549.44M |
| Stockholders Equity | $ 324.28M | $ 342.03M | $ 345.98M | $ 356.66M | $ 306.02M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 14.00M | $ -6.20M | $ -7.96M | $ 106.81M | $ -124.45M |
| Operating Cash Flow | $ 14.34M | $ -5.96M | $ -7.54M | $ 107.43M | $ -124.33M |
| Investing Cash Flow | $ -16.43M | $ -222.00K | $ -421.00K | $ -621.00K | $ 107.82M |
| Financing Cash Flow | $ -5.06M | $ -3.48M | $ -2.67M | $ -116.92M | $ -1.75M |
Amryt Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.